Please login to the form below

Not currently logged in
Email:
Password:

rheumatology

This page shows the latest rheumatology news and features for those working in and with pharma, biotech and healthcare.

Daily Brief: Tagrisso's first line approval, EULAR and EHA, and why Stephen Hawking was wrong on NHS

Rheumatology congress EULAR convenes in Amsterdam (pictured) from Wednesday, with data being presented across a range of inflammatory disorders.

Latest news

More from news
Approximately 1 fully matching, plus 79 partially matching documents found.

Latest Intelligence

  • Opening up innovation Opening up innovation

    We are trying to build a holistic portfolio. The first wave will be rheumatology. ... Prior to GSK, which he joined to lead the immuno-inflammation therapy unit, Paul-Peter worked in academia as a professor of medicine, in particular clinical immunology

  • Case study: Immunology education Case study: Immunology education

    Challenge. There are immunological links between immune-mediated inflammatory diseases (IMIDs) in dermatology, gastroenterology and rheumatology, with patients often presenting with multiple conditions. ... Setting up a virtual biologics clinic

  • Case study: Immunology education Case study: Immunology education

    Challenge. There are immunological links between immune-mediated inflammatory diseases (IMIDs) in dermatology, gastroenterology and rheumatology, with patients often presenting with multiple conditions. ... Setting up a virtual biologics clinic

  • Pharma deals during April 2014 Pharma deals during April 2014

    associated with nephrotic syndrome, certain rheumatology-related conditions, and infantile spasms.

  • Pharma deals during February 2014 Pharma deals during February 2014

    Questor and Retrophin are is now in litigation over two synthetic versions of Acthar (ACTH), a corticotropin with 19 indications, many in rare diseases including infantile spasms, MS, nephrology, and rheumatology.

More from intelligence
Approximately 0 fully matching, plus 8 partially matching documents found.

Latest appointments

More from appointments
Approximately 0 fully matching, plus 10 partially matching documents found.

Latest from PMHub

  • Event: EULAR Annual European Congress of Rheumatology 2016

    Event: EULAR Annual European Congress of Rheumatology 2016. We are delighted to be attending the EULAR Annual European Congress of Rheumatology in June.

  • EULAR Annual European Congress of Rheumatology 2017

    EULAR Annual European Congress of Rheumatology 2017. Join us at EULAR Congress 2017 in Madrid, 14-17 June. ... We are delighted to be attending and presenting at this year’ s EULAR Annual European Congress of Rheumatology in June.

  • The Biosimilar Challenge

    In fact, recent self-funded work, showed that 89% of UK payers now positively endorse the use of biosimilars across a range of therapy areas – especially in rheumatology. ... The pressure is now on to undertake the same in rheumatology, dermatology and

  • Biosimilars: Getting the flock to market

    Medical authorities including the British Gastroenterology Society and the British Society for Rheumatology have accepted the evidence that biosimilars perform as well as the originator drugs, and NICE now recommends the

  • Research Partnership announces several new appointments

    Most recently Anne was Customer Insights Partner at AbbVie where she was responsible for leading an integrated programme of analytics, market research and insight generation to support AbbVie’ s rheumatology brands.

More from PMHub
Approximately 2 fully matching, plus 17 partially matching documents found.

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
Anthill Agency

Anthill is a specialist digital agency and a strategic partner for life science companies....

Latest intelligence

Developing advocacy in the pharmaceutical industry.
The importance of advocacy programmes...
GDPR and events. What does the pharma industry need to know?
Many people in the pharma industry still aren’t following the rules set out by the GDPR when it comes to running events and attending tradeshows. But with eye-watering fines for...
Digital trends in B2B sales - how far behind is Pharma?
The modern approach to B2B sales is data-driven, and enabled by digital tools....

Infographics